Recommended Pages at phrma.org
#PhRMA12: Sanofi CEO Kicks Off the Annual Meeting | PhRMA
phrma.org — “In his opening address today, Sanofi CEO Christopher Viehbacher – speaking as the PhRMA chairman – explained why our annual meeting is being held this year in Boston: “Boston wasn’t chosen at random. We’re investing in R&D here. We’ve got some of the top world-class hospitals and universities here. The Milken Institute has consistently ranked Massachusetts as the leader of medical research and innovation in America.”” View full resource at phrma.org
Most Recently Shared on April 12, 2012 at 1:38 pm By:
joan mikardos Health Social Media
RT @kateatphrma: My post with some highlights from Viehbacher's great remarks http://t.co/6XoS6TeN #phrma12 @SanofiUS #yam
Innovation Shaping Patient Solutions | PhRMA
phrma.org — “Our guest post comes from Dennis Urbaniak, Vice President, U.S. Diabetes at Sanofi US. Tomorrow, attendees at the PhRMA Annual Meeting will be discussing ways of improving health through innovation. I wanted to share some thoughts on this important topic as it relates to diabetes.” View full resource at phrma.org
Most Recently Shared on April 11, 2012 at 5:59 pm By:
joan mikardos Health Social Media
RT @sanofius: RT @PhRMA: #Innovation Shaping Patient Solutions @DUrbaniak of @Diabetes_Sanofi talks #medinnovation http://t.co/24usmIZA #yam
Taking the Issue of Counterfeit Medicines Directly to Capitol Hill | PhRMA
phrma.org — “Today, we have a guest post from Marv Shepherd of the University of Texas.Earlier this month, the Partnership for Safe Medicines (PSM) hosted a briefing, “The Continued Impact of Counterfeit Drugs in the United States.” The event, which took place on Capitol Hill, was the latest in a series of events designed to raise awareness of the global counterfeit medicines epidemic and the need to address the issue head on.” View full resource at phrma.org
Most Recently Shared on March 29, 2012 at 1:59 pm By:
Jon J. Tripp Health Organization
We need to effectively ensure patients have access to safe & reliable #med. Read more: http://t.co/Qbs6LmgN via @PhRMA
AP Article Shows Dangers of Medicaid Prescription Drug Policies to Patients | PhRMA
phrma.org — “We all know governments are looking to save money these days. There are right ways to do it, and there are risky, misguided ways to do it.A recent article by Associated Press reporter Carla K. Johnson takes a look at Gov. Pat Quinn’s proposal in Illinois to reduce spending on medicines in the state’s Medicaid program. The article does a good job of portraying the risks associated with restricting access to prescription medicines.” View full resource at phrma.org
Most Recently Shared on March 26, 2012 at 8:02 pm By:
Jon J. Tripp Health Organization
"Dangers of Rx Drug Policies to Patients" -@GregAtPhRMA on risk of cutting #Medicaid: http://t.co/jQa6My5M On The #Catalyst #PhRMA
Setting the Record Straight on Transparency | PhRMA
phrma.org — “There’s been some chatter in the blogosphere lately around our sector’s commitment to transparency in clinical trials, with an unfortunate lack of clarity and context. To set the record straight, here’s a quick historical overview of our considerable and consistent efforts in this important area.” View full resource at phrma.org
Most Recently Shared on March 23, 2012 at 8:09 pm By:
Jon J. Tripp Health Organization
Setting the Record Straight – transparency in our sector’s history w/ #clinicaltrials http://t.co/ju8q5HSZ on The #Catalyst
Setting the Record Straight on Transparency | PhRMA
phrma.org — “There’s been some chatter in the blogosphere lately around our sector’s commitment to transparency in clinical trials, with an unfortunate lack of clarity and context. To set the record straight, here’s a quick historical overview of our considerable and consistent efforts in this important area.” View full resource at phrma.org
Most Recently Shared on March 23, 2012 at 7:23 pm By:
Jon J. Tripp Health Organization
Setting the Record Straight on #Transparency http://t.co/Wv7gWrEW via @PhRMA
Specialty Tier Placement Puts Patients at Risk | PhRMA
phrma.org — “Unless you have a keen interest in health policy — or you’ve had a personal experience in recent years — you probably haven’t spent much time thinking about specialty tiers in health plan formularies. While not exactly dinner conversation in most circles, it’s important for people to realize how a specialty tier can put patients’ health at risk. Why? It restricts access to needed treatments.” View full resource at phrma.org
Most Recently Shared on March 23, 2012 at 2:28 pm By:
Jon J. Tripp Health Organization
"Specialty Tier Placement Puts Patients at Risk" -@GregAtPhRMA explains restricted #med access on The #Catalyst http://t.co/p2oXt39Y
Every Day, Asthma | PhRMA
phrma.org — “For me certain things seem to happen every day.I hit the snooze button one too many times and spend the rest of the morning trying not to be late to work.I somehow manage to make it to my Metro stop just as my train pulls away.And there are never enough hours in the day to do everything I would like to get done.There are also certain things that happen every day in regards to asthma in the U.S., according to the Asthma and Allergy Foundation of America (AAFA)” View full resource at phrma.org
Most Recently Shared on March 23, 2012 at 1:49 pm By:
Jon J. Tripp Health Organization
#Biopharma researchers work 2 find treatments 4 #asthma every day; 74 #MedsInDev are in trial/awaiting FDA approval http://t.co/TMzcftry
Specialty Tier Placement Puts Patients at Risk | PhRMA
phrma.org — “Unless you have a keen interest in health policy — or you’ve had a personal experience in recent years — you probably haven’t spent much time thinking about specialty tiers in health plan formularies. While not exactly dinner conversation in most circles, it’s important for people to realize how a specialty tier can put patients’ health at risk. Why? It restricts access to needed treatments.” View full resource at phrma.org
Most Recently Shared on March 22, 2012 at 10:02 pm By:
Jon J. Tripp Health Organization
Specialty Tier Placement Puts #Patients at Risk http://t.co/Zamcr7zB via @PhRMA
Clinical Research and Trials Resources | PhRMA
phrma.org — “Clinical ResearchPhysicians and registered nurses are integral to the clinical research that is conducted on experimental medicines. For information on how to get involved in clinical research:” View full resource at phrma.org
Most Recently Shared on March 22, 2012 at 8:39 pm By:
Jon J. Tripp Health Organization
“Research in Your Backyard” reports on states simultaneously developing cures and creating jobs http://t.co/GVO20RT0 #MedsInDev
Big News for Brain Research | PhRMA
phrma.org — “There’s some huge news in brain research today: Microsoft co-founder Paul Allen just pledged $300 million to the Allen Institute to promote open-science research on brain circuitry. That donation will help to double the Allen Institute’s staff and fund the first four years of a ten-year project, whose plans for “brain observatories” read like something out of a science fiction movie.” View full resource at phrma.org
Most Recently Shared on March 22, 2012 at 8:25 pm By:
Jon J. Tripp Health Organization
Big News for Brain Research -@KaelanAtPhRMA on $MSFT cofounder's $300M donation to promote research http://t.co/RFUg58Lz via @PhRMA
Every Day, Asthma | PhRMA
phrma.org — “For me certain things seem to happen every day.I hit the snooze button one too many times and spend the rest of the morning trying not to be late to work.I somehow manage to make it to my Metro stop just as my train pulls away.And there are never enough hours in the day to do everything I would like to get done.There are also certain things that happen every day in regards to asthma in the U.S., according to the Asthma and Allergy Foundation of America (AAFA)” View full resource at phrma.org
Most Recently Shared on March 22, 2012 at 5:52 pm By:
New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy | PhRMA
phrma.org — “Clinical trials of new medicines target the most debilitating chronic diseasesWashington, D.C. (March 19, 2012) — Working in close collaboration with Colorado’s university medical schools, hospitals and clinical research centers, the nation’s biopharmaceutical research companies are conducting or have conducted since 1999 more than 3,000 clinical trials of new medicines in the state, a new report shows.” View full resource at phrma.org
Most Recently Shared on March 21, 2012 at 6:52 pm By:
Jon J. Tripp Health Organization
New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy http://t.co/8VpD3Usx @PhRMA
A Genome Project for Alzheimer’s | PhRMA
phrma.org — “A recent article in Newsweek brought to light to an interesting project, spearheaded by a Long Island Alzheimer’s researcher Peter Davies, to sequence the entire genome of about 1,000 Alzheimer’s patients over the next three to four years.” View full resource at phrma.org
Most Recently Shared on March 16, 2012 at 5:43 pm By:
Jon J. Tripp Health Organization
A Genome Project for Alzheimer’s http://t.co/mnDPnk0X via @PhRMA
An Essential Balance: Preserving Our Commitment to Patient Safety | PhRMA
phrma.org — “An Essential Balance: Preserving Our Commitment to Patient Safety | PhRMA” View full resource at phrma.org
Most Recently Shared on February 22, 2012 at 6:03 pm By:
@GradyAtPhRMA re: legislation on drugs; emergency docs support reform of Rx drug supplies - shortages hurt patients. http://t.co/fMBeTc2y
